首页 > 最新文献

Gaceta Medica de Bilbao最新文献

英文 中文
Técnica del ganglio centinela en el cáncer de colon 结肠癌的岗哨淋巴结技术
Q4 Medicine Pub Date : 2012-10-01 DOI: 10.1016/j.gmb.2012.06.002
José Domingo Sardón Ramos, José Errasti Alustiza, Baltasar Cermeño Toral, Eugenia Campo Cigarras, José Antonio Romeo Ramírez, Jaione Sáenz de Ugarte Sobrón, Lorena Reka Mediavilla, María Cuadra Cestafe, Virginia Moreno Nieto, Erika Miranda Serano, Begoña Atares Pueyo

Introduction

The study of lymph nodes is the most important prognostic factor in colorectal cancer without metastasis. The sentinel lymph node technique identifies the lymph node that best predicts the patient's lymph node status and allows the performance of techniques of intensive study that improve staging. The aim of this study was to evaluate the efficacy of the sentinel lymph node technique in the staging of colon cancer.

Methods

We performed a prospective study of 45 patients preoperatively diagnosed with colon cancer in stages 0, i and ii. We carried out the sentinel lymph node technique ex vivo and with methylene blue. The sentinel lymph node was studied through multiple sections and immunohistochemical techniques in addition to hematoxylin and eosin staining. We performed a comparison with a control group of 45 patients who were studied through a single section and hematoxylin and eosin staining.

Results

We identified the sentinel lymph node in 98% of the patients, with a false-negative rate of 0. Overstaging was found to occur in 4.8 to 23.8% of the patients. In patients in whom less than 12 lymph nodes were studied, overstaging was between 10.5 and 36.8%.

Conclusions

Study of sentinel lymph nodes carried out ex vivo and with methylene blue predicts the lymph node status of patients with colon cancer. This technique overstages patients to stage iii, who will receive chemotherapy, which could improve their prognosis. The benefit of this technique is greater in patients, in whom less than 12 lymph nodes are studied.

淋巴结的研究是判断结直肠癌有无转移最重要的预后因素。前哨淋巴结技术识别最能预测患者淋巴结状态的淋巴结,并允许强化研究技术的表现,以改善分期。本研究的目的是评估前哨淋巴结技术在结肠癌分期中的疗效。方法对45例术前诊断为0、i、ii期结肠癌患者进行前瞻性研究。我们进行了前哨淋巴结技术离体和亚甲基蓝。前哨淋巴结除苏木精和伊红染色外,还通过多次切片和免疫组织化学技术进行研究。我们通过单个切片和苏木精和伊红染色与对照组的45例患者进行了比较。结果我们在98%的患者中发现前哨淋巴结,假阴性率为0。4.8 ~ 23.8%的患者出现过分期。在小于12个淋巴结的患者中,分期过高的比例在10.5 - 36.8%之间。结论体外和亚甲基蓝对前哨淋巴结的研究可预测结肠癌患者的淋巴结状态。这项技术将患者提前到iii期,他们将接受化疗,这可以改善他们的预后。这项技术的好处是更大的病人,在研究少于12个淋巴结。
{"title":"Técnica del ganglio centinela en el cáncer de colon","authors":"José Domingo Sardón Ramos,&nbsp;José Errasti Alustiza,&nbsp;Baltasar Cermeño Toral,&nbsp;Eugenia Campo Cigarras,&nbsp;José Antonio Romeo Ramírez,&nbsp;Jaione Sáenz de Ugarte Sobrón,&nbsp;Lorena Reka Mediavilla,&nbsp;María Cuadra Cestafe,&nbsp;Virginia Moreno Nieto,&nbsp;Erika Miranda Serano,&nbsp;Begoña Atares Pueyo","doi":"10.1016/j.gmb.2012.06.002","DOIUrl":"10.1016/j.gmb.2012.06.002","url":null,"abstract":"<div><h3>Introduction</h3><p>The study of lymph nodes is the most important prognostic factor in colorectal cancer without metastasis. The sentinel lymph node technique identifies the lymph node that best predicts the patient's lymph node status and allows the performance of techniques of intensive study that improve staging. The aim of this study was to evaluate the efficacy of the sentinel lymph node technique in the staging of colon cancer.</p></div><div><h3>Methods</h3><p>We performed a prospective study of 45 patients preoperatively diagnosed with colon cancer in stages 0, <span>i</span> and <span>ii</span>. We carried out the sentinel lymph node technique <em>ex vivo</em> and with methylene blue. The sentinel lymph node was studied through multiple sections and immunohistochemical techniques in addition to hematoxylin and eosin staining. We performed a comparison with a control group of 45 patients who were studied through a single section and hematoxylin and eosin staining.</p></div><div><h3>Results</h3><p>We identified the sentinel lymph node in 98% of the patients, with a false-negative rate of 0. Overstaging was found to occur in 4.8 to 23.8% of the patients. In patients in whom less than 12 lymph nodes were studied, overstaging was between 10.5 and 36.8%.</p></div><div><h3>Conclusions</h3><p>Study of sentinel lymph nodes carried out <em>ex vivo</em> and with methylene blue predicts the lymph node status of patients with colon cancer. This technique overstages patients to stage <span>iii</span>, who will receive chemotherapy, which could improve their prognosis. The benefit of this technique is greater in patients, in whom less than 12 lymph nodes are studied.</p></div>","PeriodicalId":35686,"journal":{"name":"Gaceta Medica de Bilbao","volume":"109 4","pages":"Pages 135-141"},"PeriodicalIF":0.0,"publicationDate":"2012-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gmb.2012.06.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54324650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Premios Dr. José Carrasco/D. Máximo de Aguirre. VI edición, 2012 何塞·卡拉斯科博士奖/D。阿吉雷的格言。第六版,2012年
Q4 Medicine Pub Date : 2012-10-01 DOI: 10.1016/j.gmb.2012.06.003
Ricardo Franco Vicario
{"title":"Premios Dr. José Carrasco/D. Máximo de Aguirre. VI edición, 2012","authors":"Ricardo Franco Vicario","doi":"10.1016/j.gmb.2012.06.003","DOIUrl":"10.1016/j.gmb.2012.06.003","url":null,"abstract":"","PeriodicalId":35686,"journal":{"name":"Gaceta Medica de Bilbao","volume":"109 4","pages":"Pages 153-157"},"PeriodicalIF":0.0,"publicationDate":"2012-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gmb.2012.06.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54324660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sulfato de glucosamina y condroitín sulfato, fármacos para el tratamiento de la artrosis, acusados de no presentar eficacia clínica. ¿Culpables? 硫酸氨基葡萄糖和硫酸软骨素,治疗骨关节炎的药物,被指控没有临床疗效。¿有罪吗?
Q4 Medicine Pub Date : 2012-10-01 DOI: 10.1016/j.gmb.2012.08.001
Rosario Calvo

Glucosamine sulphate and chondroitin sulphate have been approved by the Spanish Medications and Health Products Agency for the symptomatic treatment of osteoarthritis arthritis. Their efficacy and safety have been demonstrated in multiple clinical studies and via meta-analyses. Recently, based on a meta-analysis published in the British Medical Journal (2010), the therapeutic advantage of glucosamine and chondroitin sulphate versus other older drugs has been seriously questioned. The publication was criticized from key opinion leaders in the field and the journal published a rectification criticizing some aspects of the paper, particularly its conclusions on a possible veto on funding and prescription of these drugs, which were not directly related to the results. The methodology employed was also widely criticized and therefore the entire paper should be interpreted with reserve. Despite subsequent support for the use of these drugs, the impact of that first publication on their funding and use remains considerable.

The present study analyzes, from a pharmacological point of view, the causes that may have contributed to a false and imprudent accusation. The aim is to define the correct place of glucosamine sulphate and chondroitin sulphate in the treatment of osteoarthritis arthritis, a chronic disease whose prevalence is increasing and which, by 2020, could become the fourth most important cause of disability worldwide.

硫酸氨基葡萄糖和硫酸软骨素已被西班牙药品和保健品管理局批准用于骨关节炎的对症治疗。其有效性和安全性已在多项临床研究和荟萃分析中得到证实。最近,根据《英国医学杂志》(2010)上发表的一项荟萃分析,氨基葡萄糖和硫酸软骨素相对于其他老药的治疗优势受到了严重质疑。该出版物受到了该领域主要意见领袖的批评,该杂志发表了一篇纠正文章,批评了该论文的某些方面,特别是其关于可能否决这些药物的资助和处方的结论,这些结论与结果没有直接关系。所采用的方法也受到了广泛的批评,因此整篇论文的解释应该有所保留。尽管后来支持使用这些药物,但首次出版物对其筹资和使用的影响仍然很大。本研究分析,从药理学的角度来看,可能导致错误和轻率的指控的原因。目的是确定硫酸氨基葡萄糖和硫酸软骨素在治疗骨关节炎中的正确地位。关节炎是一种慢性疾病,其发病率正在上升,到2020年可能成为全球第四大致残原因。
{"title":"Sulfato de glucosamina y condroitín sulfato, fármacos para el tratamiento de la artrosis, acusados de no presentar eficacia clínica. ¿Culpables?","authors":"Rosario Calvo","doi":"10.1016/j.gmb.2012.08.001","DOIUrl":"10.1016/j.gmb.2012.08.001","url":null,"abstract":"<div><p>Glucosamine sulphate and chondroitin sulphate have been approved by the Spanish Medications and Health Products Agency for the symptomatic treatment of osteoarthritis arthritis. Their efficacy and safety have been demonstrated in multiple clinical studies and via meta-analyses. Recently, based on a meta-analysis published in the British Medical Journal (2010), the therapeutic advantage of glucosamine and chondroitin sulphate versus other older drugs has been seriously questioned. The publication was criticized from key opinion leaders in the field and the journal published a rectification criticizing some aspects of the paper, particularly its conclusions on a possible veto on funding and prescription of these drugs, which were not directly related to the results. The methodology employed was also widely criticized and therefore the entire paper should be interpreted with reserve. Despite subsequent support for the use of these drugs, the impact of that first publication on their funding and use remains considerable.</p><p>The present study analyzes, from a pharmacological point of view, the causes that may have contributed to a false and imprudent accusation. The aim is to define the correct place of glucosamine sulphate and chondroitin sulphate in the treatment of osteoarthritis arthritis, a chronic disease whose prevalence is increasing and which, by 2020, could become the fourth most important cause of disability worldwide.</p></div>","PeriodicalId":35686,"journal":{"name":"Gaceta Medica de Bilbao","volume":"109 4","pages":"Pages 158-164"},"PeriodicalIF":0.0,"publicationDate":"2012-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gmb.2012.08.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54324732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Evaluación quirúrgica de la linfadenectomía pélvica por laparoscopia en el tratamiento de neoplasias ginecológicas 腹腔镜盆腔淋巴结切除术治疗妇科肿瘤的外科评价
Q4 Medicine Pub Date : 2012-10-01 DOI: 10.1016/j.gmb.2012.06.001
Alvaro Gorostiaga, Itziar Villegas, José Quílez, María Jesús Rui-Wamba, Tania Arriba, Rafael Ibarrola

Introduction

Nowadays, the approach to gynecological malignancies is surgical and pelvic lymphadenectomy is needed for staging. To do this, laparoscopy is becoming the gold standard. However, in our environment, this modality is still restricted to large university hospitals.

Material and methods

We performed a retrospective review of 26 pelvic lymphadenectomies performed at the Centro de Ginecología y Medicina Fetal in Bilbao, Basque Country, Spain, to investigate its surgical results and applicability.

Results

The mean surgical time was 90 min (70-135 min) and the mean number of nodes excised was 10.1 (2-17), with only one case of positive pelvic node. The mean time till discharge from the hospital was 2.17 days (2-3). The conversion rate to laparotomy was 0%, if patients who required laparotomy for other reasons during the oncologic intervention were excluded. There were no major complications and the rate of minor complications was low (11.53%).

Conclusions

Laparoscopic pelvic lymphadenectomy is a safe and feasible procedure and is currently the gold standard for pelvic node excision in gynecologic malignancies.

目前,妇科恶性肿瘤的治疗方法为手术治疗,分期需行盆腔淋巴结切除术。为了做到这一点,腹腔镜检查正在成为黄金标准。然而,在我们的环境中,这种模式仍然局限于大型大学医院。材料和方法我们对西班牙巴斯克地区毕尔巴鄂Ginecología胎儿医学中心进行的26例盆腔淋巴结切除术进行回顾性分析,探讨其手术效果和适用性。结果平均手术时间90 min (70 ~ 135 min),平均切除淋巴结10.1个(2 ~ 17个),仅1例盆腔淋巴结阳性。平均至出院时间2.17 d(2 ~ 3)。如果排除在肿瘤干预期间因其他原因需要开腹手术的患者,开腹转换率为0%。无重大并发症,轻微并发症发生率低(11.53%)。结论腹腔镜盆腔淋巴结切除术是一种安全可行的手术方法,是目前妇科恶性肿瘤盆腔淋巴结切除术的金标准。
{"title":"Evaluación quirúrgica de la linfadenectomía pélvica por laparoscopia en el tratamiento de neoplasias ginecológicas","authors":"Alvaro Gorostiaga,&nbsp;Itziar Villegas,&nbsp;José Quílez,&nbsp;María Jesús Rui-Wamba,&nbsp;Tania Arriba,&nbsp;Rafael Ibarrola","doi":"10.1016/j.gmb.2012.06.001","DOIUrl":"10.1016/j.gmb.2012.06.001","url":null,"abstract":"<div><h3>Introduction</h3><p>Nowadays, the approach to gynecological malignancies is surgical and pelvic lymphadenectomy is needed for staging. To do this, laparoscopy is becoming the gold standard. However, in our environment, this modality is still restricted to large university hospitals.</p></div><div><h3>Material and methods</h3><p>We performed a retrospective review of 26 pelvic lymphadenectomies performed at the Centro de Ginecología y Medicina Fetal in Bilbao, Basque Country, Spain, to investigate its surgical results and applicability.</p></div><div><h3>Results</h3><p>The mean surgical time was 90<!--> <!-->min (70-135<!--> <!-->min) and the mean number of nodes excised was 10.1 (2-17), with only one case of positive pelvic node. The mean time till discharge from the hospital was 2.17 days (2-3). The conversion rate to laparotomy was 0%, if patients who required laparotomy for other reasons during the oncologic intervention were excluded. There were no major complications and the rate of minor complications was low (11.53%).</p></div><div><h3>Conclusions</h3><p>Laparoscopic pelvic lymphadenectomy is a safe and feasible procedure and is currently the gold standard for pelvic node excision in gynecologic malignancies.</p></div>","PeriodicalId":35686,"journal":{"name":"Gaceta Medica de Bilbao","volume":"109 4","pages":"Pages 129-134"},"PeriodicalIF":0.0,"publicationDate":"2012-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gmb.2012.06.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54324643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deontología y colegios de médicos 义务论和医师学院
Q4 Medicine Pub Date : 2012-10-01 DOI: 10.1016/j.gmb.2012.06.006
Rafael Pacheco Guevara
{"title":"Deontología y colegios de médicos","authors":"Rafael Pacheco Guevara","doi":"10.1016/j.gmb.2012.06.006","DOIUrl":"10.1016/j.gmb.2012.06.006","url":null,"abstract":"","PeriodicalId":35686,"journal":{"name":"Gaceta Medica de Bilbao","volume":"109 4","pages":"Pages 125-126"},"PeriodicalIF":0.0,"publicationDate":"2012-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gmb.2012.06.006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54324679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Repercusiones del desempleo en la salud 失业对健康的影响
Q4 Medicine Pub Date : 2012-10-01 DOI: 10.1016/j.gmb.2012.06.005
Ricardo Franco-Vicario
{"title":"Repercusiones del desempleo en la salud","authors":"Ricardo Franco-Vicario","doi":"10.1016/j.gmb.2012.06.005","DOIUrl":"10.1016/j.gmb.2012.06.005","url":null,"abstract":"","PeriodicalId":35686,"journal":{"name":"Gaceta Medica de Bilbao","volume":"109 4","pages":"Pages 127-128"},"PeriodicalIF":0.0,"publicationDate":"2012-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gmb.2012.06.005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"111079081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vómitos asociados al consumo de cannabis 与大麻使用有关的呕吐
Q4 Medicine Pub Date : 2012-10-01 DOI: 10.1016/j.gmb.2012.06.004
María Luz Alarcia Ceballos , Jesús Iturralde Iriso , Edurne López de Uralde Pérez de Albeniz , Mónica Lasso de la Vega Martínez , Gregorio Mediavilla Tris , Jon González Castañeda

The prevalence of cannabis use is high in Spain. Although cannabis has a known antiemetic effect, there have been reports of cyclic and recurrent vomiting due to its use, called cannabinoid hyperemesis. The symptoms can be temporarily relieved by baths or hot showers but only disappear with cessation of cannabis use. Cannabinoid hyperemesis should be suspected in cannabis users when the results of diagnostic tests for other disorders are normal.

西班牙的大麻使用率很高。虽然大麻有已知的止吐作用,但有报道称,由于使用大麻,会出现周期性和反复呕吐,称为大麻素剧吐。这些症状可以通过洗澡或热水淋浴暂时缓解,但只有停止使用大麻才能消失。当其他疾病的诊断测试结果正常时,应怀疑大麻使用者有大麻素呕吐。
{"title":"Vómitos asociados al consumo de cannabis","authors":"María Luz Alarcia Ceballos ,&nbsp;Jesús Iturralde Iriso ,&nbsp;Edurne López de Uralde Pérez de Albeniz ,&nbsp;Mónica Lasso de la Vega Martínez ,&nbsp;Gregorio Mediavilla Tris ,&nbsp;Jon González Castañeda","doi":"10.1016/j.gmb.2012.06.004","DOIUrl":"10.1016/j.gmb.2012.06.004","url":null,"abstract":"<div><p>The prevalence of cannabis use is high in Spain. Although cannabis has a known antiemetic effect, there have been reports of cyclic and recurrent vomiting due to its use, called cannabinoid hyperemesis. The symptoms can be temporarily relieved by baths or hot showers but only disappear with cessation of cannabis use. Cannabinoid hyperemesis should be suspected in cannabis users when the results of diagnostic tests for other disorders are normal.</p></div>","PeriodicalId":35686,"journal":{"name":"Gaceta Medica de Bilbao","volume":"109 4","pages":"Pages 151-152"},"PeriodicalIF":0.0,"publicationDate":"2012-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gmb.2012.06.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54324669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Legislación sobre formación y utilización de desfibriladores externos semiautomáticos en España: análisis de la situación actual fuera del ámbito sanitario 西班牙关于半自动体外除颤器的培训和使用的立法:卫生领域以外的现状分析
Q4 Medicine Pub Date : 2012-10-01 DOI: 10.1016/j.gmb.2012.06.007
Sendoa Ballesteros Peña

Objectives

To compare Spanish regional laws on the training and use of automated external defibrillators (AED) in the out-of-hospital setting and to analyze the current situation and regional variation in the development of these regulations.

Methodology

We reviewed the regulations published in Official Bulletins until January 2012, extracting data for the conditions required to use an AED, training methodologies, the duration of initial and continuous training, the legal validity of certificates, and the entities accredited to impart AED training.

Results

Sixteen autonomous regions have developed regulatory standards on AED. Except for the Basque Country, the remaining regions allow medical staff to use AED devices, sometimes including nurses and other emergency staff. For all other persons, training programs are established, with varying duration.

Conclusions

Legislation on the training and utilization of AED devices has been developed independently in each region, leading to heterogeneous models.

目的比较西班牙各地区关于院外自动体外除颤器(AED)培训和使用的法律,分析这些法规制定的现状和地区差异。方法:我们回顾了2012年1月之前发布在官方公报上的法规,提取了使用AED所需的条件、培训方法、初始和持续培训的持续时间、证书的法律有效性以及获得认可的提供AED培训的实体的数据。结果16个自治区制定了AED的监管标准。除巴斯克地区外,其余地区允许医务人员使用AED设备,有时包括护士和其他急救人员。对于所有其他人员,建立了培训计划,时间长短不一。结论各地区对AED设备培训和使用的立法都是独立制定的,导致了不同的模式。
{"title":"Legislación sobre formación y utilización de desfibriladores externos semiautomáticos en España: análisis de la situación actual fuera del ámbito sanitario","authors":"Sendoa Ballesteros Peña","doi":"10.1016/j.gmb.2012.06.007","DOIUrl":"10.1016/j.gmb.2012.06.007","url":null,"abstract":"<div><h3>Objectives</h3><p>To compare Spanish regional laws on the training and use of automated external defibrillators (AED) in the out-of-hospital setting and to analyze the current situation and regional variation in the development of these regulations.</p></div><div><h3>Methodology</h3><p>We reviewed the regulations published in Official Bulletins until January 2012, extracting data for the conditions required to use an AED, training methodologies, the duration of initial and continuous training, the legal validity of certificates, and the entities accredited to impart AED training.</p></div><div><h3>Results</h3><p>Sixteen autonomous regions have developed regulatory standards on AED. Except for the Basque Country, the remaining regions allow medical staff to use AED devices, sometimes including nurses and other emergency staff. For all other persons, training programs are established, with varying duration.</p></div><div><h3>Conclusions</h3><p>Legislation on the training and utilization of AED devices has been developed independently in each region, leading to heterogeneous models.</p></div>","PeriodicalId":35686,"journal":{"name":"Gaceta Medica de Bilbao","volume":"109 4","pages":"Pages 142-150"},"PeriodicalIF":0.0,"publicationDate":"2012-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gmb.2012.06.007","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54324700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Algunos aspectos de la hipersensibilidad alérgica alimentaria a frutas y vegetales 对水果和蔬菜过敏的一些方面
Q4 Medicine Pub Date : 2012-07-01 DOI: 10.1016/j.gmb.2012.04.004
Ángel San Miguel Hernández, Blanca Martin, Alicia Armentia Medina

We review some features of food allergy and discuss the problems caused by cross-reactivity between proteins from distinct foods, as well as common questions and their possible answers.

我们回顾了食物过敏的一些特征,讨论了不同食物的蛋白质之间的交叉反应所引起的问题,以及常见的问题和可能的答案。
{"title":"Algunos aspectos de la hipersensibilidad alérgica alimentaria a frutas y vegetales","authors":"Ángel San Miguel Hernández,&nbsp;Blanca Martin,&nbsp;Alicia Armentia Medina","doi":"10.1016/j.gmb.2012.04.004","DOIUrl":"10.1016/j.gmb.2012.04.004","url":null,"abstract":"<div><p>We review some features of food allergy and discuss the problems caused by cross-reactivity between proteins from distinct foods, as well as common questions and their possible answers.</p></div>","PeriodicalId":35686,"journal":{"name":"Gaceta Medica de Bilbao","volume":"109 3","pages":"Pages 104-112"},"PeriodicalIF":0.0,"publicationDate":"2012-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gmb.2012.04.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54324625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Linfangitis carcinomatosa pulmonar. Una excepcional forma de presentación del cáncer de colon 肺癌性淋巴管炎。结肠癌的一种特殊表现形式
Q4 Medicine Pub Date : 2012-07-01 DOI: 10.1016/j.gmb.2012.02.001
Carlos Placer, Maialen Alkorta, José María Enriquez-Navascués
{"title":"Linfangitis carcinomatosa pulmonar. Una excepcional forma de presentación del cáncer de colon","authors":"Carlos Placer,&nbsp;Maialen Alkorta,&nbsp;José María Enriquez-Navascués","doi":"10.1016/j.gmb.2012.02.001","DOIUrl":"10.1016/j.gmb.2012.02.001","url":null,"abstract":"","PeriodicalId":35686,"journal":{"name":"Gaceta Medica de Bilbao","volume":"109 3","pages":"Pages 120-121"},"PeriodicalIF":0.0,"publicationDate":"2012-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gmb.2012.02.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54324553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Gaceta Medica de Bilbao
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1